<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0245">
 <label>49</label>
 <mixed-citation publication-type="other" id="or0020">Center for Biologics Evaluation and Research, U. S. F. and D. A. (n.d.). Recommendations for investigational COVID-19 convalescent plasma. Retrieved from 
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" id="ir0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>.
 </mixed-citation>
</ref>
